pIgR and PECAM-1 bind to pneumococcal adhesins RrgA and PspC mediating bacterial brain invasion.
Federico IovinoJoo-Yeon Engelen-LeeMatthijs BrouwerDiederik van de BeekArie van der EndeMerche Valls SeronPeter MellrothSandra MuschiolJan BergstrandJerker WidengrenBirgitta Henriques-NormarkPublished in: The Journal of experimental medicine (2017)
Streptococcus pneumoniae is the main cause of bacterial meningitis, a life-threating disease with a high case fatality rate despite treatment with antibiotics. Pneumococci cause meningitis by invading the blood and penetrating the blood-brain barrier (BBB). Using stimulated emission depletion (STED) super-resolution microscopy of brain biopsies from patients who died of pneumococcal meningitis, we observe that pneumococci colocalize with the two BBB endothelial receptors: polymeric immunoglobulin receptor (pIgR) and platelet endothelial cell adhesion molecule (PECAM-1). We show that the major adhesin of the pneumococcal pilus-1, RrgA, binds both receptors, whereas the choline binding protein PspC binds, but to a lower extent, only pIgR. Using a bacteremia-derived meningitis model and mutant mice, as well as antibodies against the two receptors, we prevent pneumococcal entry into the brain and meningitis development. By adding antibodies to antibiotic (ceftriaxone)-treated mice, we further reduce the bacterial burden in the brain. Our data suggest that inhibition of pIgR and PECAM-1 has the potential to prevent pneumococcal meningitis.
Keyphrases
- cerebrospinal fluid
- resting state
- white matter
- binding protein
- functional connectivity
- cell adhesion
- cerebral ischemia
- endothelial cells
- risk factors
- multiple sclerosis
- high throughput
- wild type
- electronic health record
- type diabetes
- metabolic syndrome
- combination therapy
- single molecule
- cancer therapy
- gram negative
- skeletal muscle
- high speed
- artificial intelligence
- drug release